ArticleAmerican journal of translational research2026

Alterations in peripheral blood inflammatory mediators, vascular endothelial growth factor, and serum tumor markers in advanced non-small cell lung cancer patients treated with bevacizumab combined with chemotherapy.

Zonghua Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.